Skip to main content
Filing year 2024

The Jed Ian Taxel Foundation for Rare Cancer Research Inc

Park City, Utah·EIN 86-2610819·NTEE H30 · Medical Research·3
Total revenue
$309k
Total assets
$149k
Total expenses
$394k
Reported officers
13
Mission

To inspire and empower scientific breakthroughs, clinical trials and improved treatments which change lives and enable better outcomes for rare cancer patients and their families.

Executive compensation

Form 990 · Schedule J · 1 reported individual · Filing year 2024

$40k
$43k

Teal figures restate each filed amount in 2026 dollars.

Estimated with BLS CPI-U for the West region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 12 unpaid individuals.

Browse compensation in Medical Research

Financial trend

Revenue and expenses over time

The Jed Ian Taxel Foundation for Rare Cancer Research Inc reported revenue and expenses across 2 filing years.

RevenueExpenses
$274k
$288k
2023
$309k
$394k
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Medical Research executives earn

Comparable medical research organizations nationwide pay their highest-earning executive a median of $114,840.

25th percentile
$40k
Median
$114,840
75th percentile
$234k
90th percentile
$424k

These are medical research sector-wide figures, not this organization's reported pay. Based on 283 organizations across 283 filings (2021 – 2023).

See full Medical Research compensation data
Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.